Whether you prefer coffee, fruity flavors, or nutty delights, theres a smoothie for everyone
While these medications produce gastrointestinal effects that have raised theoretical concerns, current evidence does not establish a causal link between GLP-1 drugs and colorectal cancer
Recently, liraglutide has gained increasing attention owing to its anti-inflammatory activities in age-related diseases 30
Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents with Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials
These drugs have become vital tools in addressing the root causes of chronic diseasesobesity, cardiovascular disorders, PCOS, liver and kidney disease, and possibly even neurodegeneration
Future pharmaceutical CagriSema Anticipated FDA approval: Phase 3 trials completed FDA submission expected 2024-2025 Approval likely 2025-2026 Brand name: CagriSema Pharmaceutical pricing (projected): Likely $1,200-1,500/month without insurance Similar to Wegovy/Zepbound pricing Insurance coverage uncertain initially Patient assistance programs may be available Insurance considerations: May cover if BMI 30 with comorbidity Or BMI 27 with diabetes/hypertension Prior authorization required Step therapy (try semaglutide first) When pharmaceutical available: Easier administration (pre-filled pen likely) Medical support included Quality guaranteed Prescription required May or may not be cheaper than research peptides Troubleshooting CagriSema dosing issues Common problems and solutions
